勘误：2017 - 2030年沙特阿拉伯和阿拉伯联合酋长国的非酒精性脂肪性肝病负担
Erratum: Nonalcoholic fatty liver disease burden - Saudi Arabia and United Arab Emirates, 2017-2030.
出版信息
Saudi J Gastroenterol. 2018 Jul-Aug;24(4):255. doi: 10.4103/1319-3767.237645.
Abstract
[This corrects the article DOI: 10.4103/sjg.SJG_122_18].
摘要
[本文更正了文章的数字对象标识符：10.4103/sjg.SJG_122_18]。
相似文献
1
Erratum: Nonalcoholic fatty liver disease burden - Saudi Arabia and United Arab Emirates, 2017-2030.勘误：2017 - 2030年沙特阿拉伯和阿拉伯联合酋长国的非酒精性脂肪性肝病负担
Saudi J Gastroenterol. 2018 Jul-Aug;24(4):255. doi: 10.4103/1319-3767.237645.
2
Nonalcoholic fatty liver disease burden - Saudi Arabia and United Arab Emirates, 2017-2030.2017 - 2030年沙特阿拉伯和阿拉伯联合酋长国的非酒精性脂肪性肝病负担
Saudi J Gastroenterol. 2018 Jul-Aug;24(4):211-219. doi: 10.4103/sjg.SJG_122_18.
3
Clinical and economic burden of nonalcoholic steatohepatitis in Saudi Arabia, United Arab Emirates and Kuwait.沙特阿拉伯、阿拉伯联合酋长国和科威特的非酒精性脂肪性肝炎的临床和经济负担。
Hepatol Int. 2021 Aug;15(4):912-921. doi: 10.1007/s12072-021-10182-x. Epub 2021 Apr 6.
4
The effect of bariatric surgeries on nonalcoholic fatty liver disease: Erratum.减肥手术对非酒精性脂肪性肝病的影响：勘误
Saudi J Gastroenterol. 2015 Sep-Oct;21(5):341. doi: 10.4103/1319-3767.166209.
5
Impact of corporate governance mechanism on IFRS adoption: A comparative study of Saudi Arabia, Oman, and the United Arab Emirates.公司治理机制对采用国际财务报告准则的影响：沙特阿拉伯、阿曼和阿拉伯联合酋长国的比较研究。
Heliyon. 2021 Jan 6;7(1):e05848. doi: 10.1016/j.heliyon.2020.e05848. eCollection 2021 Jan.
6
Comparing Life Expectancy Determinants between Saudi Arabia and United Arab Emirates from 1980-2020.比较1980年至2020年沙特阿拉伯和阿拉伯联合酋长国的预期寿命决定因素。
Eur J Investig Health Psychol Educ. 2023 Jul 13;13(7):1293-1305. doi: 10.3390/ejihpe13070095.
7
Management of nonalcoholic fatty liver disease in the Middle East.中东地区非酒精性脂肪性肝病的管理
World J Gastroenterol. 2020 Jul 7;26(25):3528-3541. doi: 10.3748/wjg.v26.i25.3528.
8
The clinical & economic burden of treatment-resistant depression in the Gulf-Cooperation Council: The Kingdom of Saudi Arabia, Kuwait and the United Arab Emirates.治疗抵抗性抑郁症在海湾合作委员会国家（沙特阿拉伯、科威特和阿拉伯联合酋长国）的临床和经济负担。
Int J Methods Psychiatr Res. 2023 Sep;32(3):e1952. doi: 10.1002/mpr.1952. Epub 2022 Nov 26.
9
Epidemiology of headache in Arab countries.头痛在阿拉伯国家的流行病学。
J Headache Pain. 2010 Feb;11(1):1-3. doi: 10.1007/s10194-009-0173-8. Epub 2009 Dec 1.
10
Systematic thematic review of e-health research in the Gulf Cooperation Council (Arabian Gulf): Bahrain, Kuwait, Oman, Qatar, Saudi Arabia and United Arab Emirates.系统主题评价海湾合作委员会（阿拉伯湾）的电子健康研究：巴林、科威特、阿曼、卡塔尔、沙特阿拉伯和阿拉伯联合酋长国。
J Telemed Telecare. 2017 May;23(4):452-459. doi: 10.1177/1357633X16647894. Epub 2016 May 28.
引用本文的文献
1
Fibroblast Growth Factor 21: A More Effective Biomarker Than Free Fatty Acids and Other Insulin Sensitivity Measures for Predicting Non-alcoholic Fatty Liver Disease in Saudi Arabian Type 2 Diabetes Patients.成纤维细胞生长因子21：在预测沙特阿拉伯2型糖尿病患者非酒精性脂肪性肝病方面，比游离脂肪酸及其他胰岛素敏感性指标更有效的生物标志物。
Cureus. 2023 Dec 14;15(12):e50524. doi: 10.7759/cureus.50524. eCollection 2023 Dec.
2
Exploring the Validity of Available Markers and Indices in the Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD) in People with Type 2 Diabetes in Saudi Arabia.探索沙特阿拉伯2型糖尿病患者中非酒精性脂肪性肝病（NAFLD）诊断中现有标志物和指标的有效性。
Diseases. 2023 Jan 15;11(1):10. doi: 10.3390/diseases11010010.
本文引用的文献
1
The effect of virulence genotypes of on eradication therapy in children.（此处英文文本似乎不完整，“of”后面缺少具体内容）关于儿童根除治疗的毒力基因型的影响。
Saudi J Gastroenterol. 2018 Jul-Aug;24(4):249-254. doi: 10.4103/sjg.SJG_579_17.
Zotero 插件